- Home
- SFM vs ROIV Comparison
SFM vs ROIV Comparison
Compare SFM & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SFM | ROIV |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Food Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 14.1B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | SFM | ROIV |
|---|---|---|
| Price | $80.48 | $21.67 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 8 |
| Target Price | ★ $138.64 | $21.94 |
| AVG Volume (30 Days) | 2.0M | ★ 6.7M |
| Earning Date | 10-29-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 49.03 | N/A |
| EPS | ★ 5.15 | N/A |
| Revenue | ★ $8,653,696,000.00 | $20,329,000.00 |
| Revenue This Year | $15.28 | N/A |
| Revenue Next Year | $9.86 | $376.94 |
| P/E Ratio | $15.45 | ★ N/A |
| Revenue Growth | ★ 16.60 | N/A |
| 52 Week Low | $75.75 | $8.73 |
| 52 Week High | $182.00 | $22.45 |
Technical Indicators
Market Signals| Indicator | SFM | ROIV |
|---|---|---|
| Relative Strength Index (RSI) | 38.08 | 62.44 |
| Support Level | $79.24 | $20.14 |
| Resistance Level | $87.35 | $21.48 |
| Average True Range (ATR) | 2.34 | 0.71 |
| MACD | 0.40 | 0.00 |
| Stochastic Oscillator | 20.41 | 65.96 |
Price Performance
Historical ComparisonAbout SFM Sprouts Farmers Market Inc.
Sprouts Farmers Market Inc offers a specialty grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspire wellness naturally with a carefully curated assortment products paired with purpose-driven people. The company continues to bring products made with lifestyle-friendly ingredients such as organic, plant-based, and gluten-free. It approximately has 407 stores in nearly 23 states. The Company has one operating segment that is healthy grocery stores.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.